How to Get Garadacimab (Andembry) Covered by UnitedHealthcare in Florida: Prior Authorization, Appeals, and Cost Guide 2025
Answer Box: Getting Garadacimab Covered by UnitedHealthcare in Florida
UnitedHealthcare requires prior authorization for Garadacimab (Andembry) in Florida through OptumRx, with mandatory step therapy documentation showing failure of preferred HAE prophylactics. Submit via the OptumRx Provider Portal with HAE diagnosis confirmation, prior therapy records, and specialist prescription. Standard review takes 1-5 business days; expedited review 24-72 hours. If denied, file internal appeals within 180 days, followed by Florida's external review process within 4 months.
First step today: Call UnitedHealthcare Member Services at 1-800-711-4555 to verify your plan's formulary tier, copay, and specific PA requirements for Garadacimab.
Table of Contents
- Plan Types & Coverage Implications
- Formulary Status & Tier Placement
- Prior Authorization Requirements
- Specialty Pharmacy Network
- Cost-Share Dynamics
- Step-by-Step: Fastest Path to Approval
- Appeals Process in Florida
- Common Denial Reasons & Solutions
- FAQ: Garadacimab Coverage Questions
Plan Types & Coverage Implications
UnitedHealthcare offers several plan types in Florida, each with different coverage rules for Garadacimab:
HMO Plans: Require referrals to specialists and typically have more restrictive networks. You'll need a referral from your primary care physician to see an immunologist or allergist who can prescribe Garadacimab.
PPO Plans: Allow direct access to specialists without referrals, making it easier to see the required specialist for HAE treatment. However, staying in-network provides better coverage.
EPO Plans: Combine features of HMO and PPO plans. No referrals needed for specialists, but coverage is limited to in-network providers only.
Medicare Advantage: For 2026, Garadacimab falls under Tier 5 (Specialty Tier) with 30-33% coinsurance after any applicable deductible. Some plans have $0 deductibles for certain tiers, while others require meeting a $270 Part D deductible.
All UnitedHealthcare plan types in Florida follow the same prior authorization criteria for Garadacimab, with no state-specific deviations from national policies.
Formulary Status & Tier Placement
| Coverage Aspect | Details | Source |
|---|---|---|
| Formulary Status | Covered on specialty tier (Tier 4/5) | UHC Commercial PDL |
| Prior Authorization | Required for all plans | OptumRx PA Policy |
| Step Therapy | Must document failure of preferred HAE prophylactics | UHC Provider Portal |
| Quantity Limits | Per FDA labeling (150mg SC monthly) | PA Notification Form |
Garadacimab is listed as a specialty medication requiring prior authorization across all UnitedHealthcare formularies. Unlike some specialty drugs, it does not require REMS training enrollment, which simplifies the approval process.
Prior Authorization Requirements
HAE Diagnosis Documentation
Your specialist must provide laboratory confirmation of hereditary angioedema:
- Type I/II HAE: C1-INH antigenic/functional levels below normal limits
- Low C4 levels and corresponding C1-INH dysfunction
- ICD-10 code D84.1 for hereditary angioedema
- Attack frequency documentation showing typically 2+ attacks per month
Step Therapy Documentation
UnitedHealthcare requires proof that you've tried and failed other HAE prophylaxis medications:
Required Documentation:
- Dates of all previously tried therapies (danazol, tranexamic acid, berotralstat/Orladeyo)
- Specific reasons for discontinuation (inefficacy, adverse effects, contraindications)
- Clinical evidence demonstrating failure or intolerance to each medication
- Duration of each trial and outcomes
Specialist Prescription Requirement
Garadacimab must be prescribed by:
- Immunologist
- Allergist
- Hematologist
Primary care physicians typically cannot initiate prior authorization requests for this medication.
Specialty Pharmacy Network
Garadacimab must be dispensed through UnitedHealthcare's preferred specialty pharmacy network:
Primary Options:
- OptumRx Specialty Pharmacy
- Accredo (Evernorth)
- CVS Specialty
- Walgreens Specialty Pharmacy
Setup Process:
- Provider submits PA approval
- Specialty pharmacy contacts patient for enrollment
- Cold chain storage and administration training provided
- Monthly shipments coordinated with injection schedule
Tip: Call UnitedHealthcare Member Services at 1-800-711-4555 to confirm which specialty pharmacies in your area stock Garadacimab and can coordinate with your healthcare team.
Cost-Share Dynamics
Commercial Plans
- Specialty Tier: High copays or coinsurance (typically 20-50% after deductible)
- Deductible: Most plans require meeting your annual deductible first
- Out-of-pocket maximum: Counts toward your annual limit
Medicare Advantage (2026)
- Tier 5 Specialty: 30-33% coinsurance
- Part D Deductible: $0-$270 depending on plan
- Catastrophic Coverage: $0 cost-sharing after reaching out-of-pocket threshold
Cost-Saving Options:
- CSL Behring patient assistance programs
- Copay assistance cards (for commercial plans)
- Foundation grants for HAE patients
- 340B pricing at qualified health centers
Step-by-Step: Fastest Path to Approval
Step 1: Verify Coverage (Patient/Clinic - Day 1)
Call UnitedHealthcare Member Services at 1-800-711-4555 with this script: "I need to verify coverage for Garadacimab (Andembry) for hereditary angioedema. Can you tell me the formulary tier, copay amount, prior authorization requirements, and preferred specialty pharmacies?"
Step 2: Gather Documentation (Clinic - Days 1-3)
Required Documents:
- HAE laboratory results (C4, C1-INH levels)
- Attack frequency logs
- Prior therapy records with dates and outcomes
- Current specialist consultation notes
Step 3: Submit Prior Authorization (Provider - Day 3-4)
Submit through OptumRx Provider Portal with complete documentation package including medical necessity letter addressing:
- Clinical problem with HAE diagnosis
- Complete prior treatment history
- Why Garadacimab is medically necessary
- Expected outcomes and monitoring plan
Step 4: Track Status (Days 4-8)
- Electronic submissions: 2-3 business days
- Expedited reviews: 24-72 hours
- Check status via provider portal or call OptumRx
Step 5: Respond to Information Requests (If needed)
Respond within 24-48 hours using the same submission method to avoid processing delays.
Step 6: Coordinate Specialty Pharmacy (Upon Approval)
Work with approved specialty pharmacy to:
- Complete patient enrollment
- Schedule delivery and administration training
- Set up ongoing refill schedule
Step 7: Plan for Reauthorization (Month 11)
Submit renewal 30-60 days before expiration with:
- Updated attack frequency data
- Adherence documentation
- Continued medical necessity
Appeals Process in Florida
Internal Appeals
| Appeal Level | Timeline to File | Review Period | How to Submit |
|---|---|---|---|
| First Level | 180 days from denial | 30 days (72 hours urgent) | UHC member portal, mail, or fax |
| Second Level | 60 days from first denial | 30 days (72 hours urgent) | Same methods as first level |
Required Documents:
- Updated medical necessity letter
- Additional clinical documentation
- Relevant treatment guidelines
- Attack frequency data
External Review (Florida)
After exhausting internal appeals, Florida residents can request external review through the Florida Department of Financial Services:
- Timeline: 4 months after final internal denial
- Process: Independent medical expert reviews case
- Cost: No charge to consumer
- Decision: Binding on UnitedHealthcare if approved
Contact Information: Florida Department of Financial Services Division of Consumer Services Insurance Consumer Helpline: 1-877-693-5236
From our advocates: We've seen successful appeals for specialty HAE medications when providers include detailed attack logs showing frequency and severity, along with clear documentation of why other prophylactic options failed. The key is demonstrating that Garadacimab specifically addresses unmet medical needs that other covered alternatives cannot.
Common Denial Reasons & Solutions
| Denial Reason | Solution Strategy | Required Documentation |
|---|---|---|
| Lack of HAE confirmation | Submit complete lab workup | C4, C1-INH levels, genetic testing if applicable |
| Insufficient step therapy | Document all prior prophylaxis trials | Dates, dosages, duration, specific reasons for discontinuation |
| Missing specialist prescription | Transfer care to immunologist/allergist | Specialist consultation notes and prescription |
| Inadequate attack documentation | Provide detailed attack logs | Frequency, severity, impact on quality of life |
| REMS concerns | Clarify no REMS required | Reference FDA labeling and UHC policy |
Appeal Template Elements:
- Patient demographics and insurance information
- HAE diagnosis with laboratory confirmation
- Complete prior therapy history with specific outcomes
- Clinical rationale for Garadacimab necessity
- Expected treatment goals and monitoring plan
- Relevant clinical guidelines and FDA labeling references
For complex cases, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to create point-by-point rebuttals aligned with UnitedHealthcare's own coverage rules.
FAQ: Garadacimab Coverage Questions
Q: How long does UnitedHealthcare prior authorization take in Florida? A: Standard electronic submissions take 2-3 business days. Expedited reviews for urgent cases are completed within 24-72 hours. Call OptumRx at 1-800-711-4555 for expedited processing if clinically appropriate.
Q: What if Garadacimab is non-formulary on my plan? A: Garadacimab is on UnitedHealthcare's specialty formulary as of 2025. If your specific plan shows it as non-formulary, request a formulary exception with medical necessity documentation.
Q: Can I request an expedited appeal in Florida? A: Yes, for urgent medical situations. Both internal appeals and external reviews offer expedited timelines (72 hours for internal, similar for external) when delays could seriously jeopardize your health.
Q: Does step therapy apply if I tried other medications outside Florida? A: Yes, UnitedHealthcare accepts documentation of prior therapy trials from any location, as long as you have proper medical records showing dates, dosages, and reasons for discontinuation.
Q: What's the difference between prior authorization and step therapy? A: Prior authorization is the approval process required before coverage. Step therapy is a specific requirement within that process, mandating you try preferred (usually less expensive) medications first.
Q: How much will Garadacimab cost with UnitedHealthcare? A: Costs vary by plan type. Commercial plans typically have high specialty tier copays or coinsurance (20-50%). Medicare Advantage plans charge 30-33% coinsurance. Contact Member Services for your specific cost-sharing amounts.
Q: Can my primary care doctor prescribe Garadacimab? A: No, UnitedHealthcare requires prescriptions from specialists: immunologists, allergists, or hematologists who have expertise in HAE management.
Q: What happens if I move within Florida? A: Your UnitedHealthcare coverage and prior authorization should remain valid. Verify your new address is within your plan's service area and update your preferred specialty pharmacy if needed.
Sources & Further Reading
- UHC Prior Authorization Policy for Andembry (PDF)
- OptumRx Provider Portal - Specialty Drug PA
- UHC Commercial Preferred Drug List
- Florida Department of Financial Services - Insurance Appeals
- CSL Behring Andembry Prescribing Information
For personalized assistance with UnitedHealthcare denials and appeals, Counterforce Health provides specialized support for patients and providers navigating complex prior authorization requirements for specialty medications like Garadacimab.
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and requirements may change. Always verify current information with UnitedHealthcare directly and consult with your healthcare provider regarding treatment decisions. For official Florida insurance regulations and appeal rights, contact the Florida Department of Financial Services.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.